BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3923141)

  • 1. Purification and characterization of placental plasminogen activator (PPA).
    Kobayashi T; Terao T
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 May; 37(5):783-92. PubMed ID: 3923141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of placental urokinase inhibitor in toxemia of pregnancy.
    Terao T; Kobayashi T
    Biol Res Pregnancy Perinatol; 1983; 4(4):145-51. PubMed ID: 6360225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and purification of plasminogen activator from Yoshida ascites Sarcoma of rats.
    Nulkar MW; Pawse AR
    Indian J Biochem Biophys; 1991 Feb; 28(1):46-51. PubMed ID: 1905268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.
    Toki N; Sumi H; Sasaki K; Boreisha I; Robbins KC
    J Clin Invest; 1985 Apr; 75(4):1212-22. PubMed ID: 3921568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human leucocyte urokinase inhibitor--purification, characterization and comparative studies against different plasminogen activators.
    Kopitar M; Rozman B; Babnik J; Turk V; Mullins DE; Wun TC
    Thromb Haemost; 1985 Dec; 54(4):750-5. PubMed ID: 3879018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen-activator in human early milk: its partial purification and characterization.
    Okamoto U; Horie N; Nagamatsu Y; Yamamoto JI
    Thromb Haemost; 1981 Apr; 45(2):121-6. PubMed ID: 7196095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator.
    Astedt B; Lecander I; Brodin T; Lundblad A; Löw K
    Thromb Haemost; 1985 Feb; 53(1):122-5. PubMed ID: 3922076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of plasminogen activator from two human renal carcinoma cell lines.
    Nelson NF; Cieplak W; Dacus SC; Prager MD
    J Cell Physiol; 1986 Mar; 126(3):435-43. PubMed ID: 2419348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of tissue plasminogen activator from skin lesions with allergic vasculitis.
    Toki N; Tsushima H; Yamasaki M; Yamasaki R; Yamura T
    J Invest Dermatol; 1982 Jan; 78(1):18-23. PubMed ID: 7198668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An inhibitor of plasminogen activation from human placenta. Purification and characterization.
    Wun TC; Reich E
    J Biol Chem; 1987 Mar; 262(8):3646-53. PubMed ID: 3102492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of plasminogen activator produced by an established cell line from human ovary.
    Matsuo C; Fukao H; Matsuo O
    J Cell Physiol; 1988 Feb; 134(2):253-60. PubMed ID: 3126195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on the immunohistochemical localization of coagulation fibrinolysis factors in the placenta, especially of placental plasminogen activator (PPA)].
    Kyodo Y; Kobayashi T; Terao T
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jan; 38(1):10-6. PubMed ID: 3512741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of the plasminogen activator secreted by a rat brain tumor cell line in culture.
    Bykowska K; Rijken DC; Collen D
    Thromb Haemost; 1981 Oct; 46(3):642-4. PubMed ID: 7198301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Isolation and characteristics of urokinase-type plasminogen activator from a culture of human embryo lung fibroblasts].
    Shevelev AIa; Barshevskaia TN; Belogurov AA; Kratasiuk GA; Goriunova LE
    Mol Biol (Mosk); 1986; 20(3):778-88. PubMed ID: 3088432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Purification and properties of plasminogen activator from human blood plasma after sudden death].
    Petrenko OA
    Biokhimiia; 1978 Aug; 43(8):1438-43. PubMed ID: 153771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of tissue-type plasminogen activator in maxillary mucosa with chronic inflammation.
    Hamaguchi Y; Ohi M; Sakakura Y; Miyoshi Y
    Thromb Haemost; 1985 Aug; 54(2):485-9. PubMed ID: 3936218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial purification and characterization of native plasminogen activators from bovine milk.
    Deharveng G; Nielsen SS
    J Dairy Sci; 1991 Jul; 74(7):2060-72. PubMed ID: 1894805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On a plasminogen activator from human plasma.
    Batista AD; Solana GH; Almonte JF
    Thromb Haemost; 1980 Feb; 42(5):1607-14. PubMed ID: 6899948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays.
    Camiolo SM; Greco WR
    Cancer Res; 1986 Apr; 46(4 Pt 1):1788-94. PubMed ID: 3081257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.